News

H1N1 Experiences Point to Control Strategies


 

Disclosures: Dr. Lee's study was supported by the Singapore Ministry of Defense; the National University of Singapore; and the Singapore Agency for Science, Research, and Technology. Dr. Cowling's study was supported by the National Institute of Allergy and Infectious Diseases (U.S.) and Hong Kong University. Dr. Lee's associates reported ties to GlaxoSmithKline, Novartis, Adamas Pharmaceuticals, Baxter, MerLion Pharmaceuticals, Pfizer, and Wyeth.

Pages

Recommended Reading

H1N1 Accounts for 99% of Influenza A in U.S.
MDedge Internal Medicine
CDC Reports Rising Congenital Syphilis Rates
MDedge Internal Medicine
High-Dose Seasonal Flu Vaccine Ready for 2010–2011
MDedge Internal Medicine
Federal Agencies Investigating Adverse Effects of H1N1 Vaccine
MDedge Internal Medicine
Urethritis Common in Asymptomatic Men
MDedge Internal Medicine
H1N1 Hospitalizations Rise Again in Georgia
MDedge Internal Medicine
H1N1 Vaccination Patterns Show Marked State Variation
MDedge Internal Medicine
Young Women Uneducated About STD Testing
MDedge Internal Medicine
Green Tea Ointment Seems Effective for Genital Warts
MDedge Internal Medicine
Seroprevalence of HSV-2 Is 48% Among African American Women
MDedge Internal Medicine